Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
1993.
Bibliography.
Acta Psychiatrica Scandinavica,
Vol. 88,
Issue. S374,
p.
45.
Figueras, Albert
and
Capellà, Dolors
1993.
Vol. 17,
Issue. ,
p.
49.
Parry, A. K.
Ormerod, L. P.
Hamlin, G. W.
and
Saleem, P. T.
1994.
Recurrent Sinus Arrest in Association with Neuroleptic Malignant Syndrome.
British Journal of Psychiatry,
Vol. 164,
Issue. 5,
p.
689.
Carroll, Brendan T.
and
Spetie, Lacramioara
1994.
Catatonia on the Consultation-Liaison Service: A Replication Study.
The International Journal of Psychiatry in Medicine,
Vol. 24,
Issue. 4,
p.
329.
Velamoor, Vr
Swamy, Gn
Parmar, Late-Rs
Williamson, P
and
Caroff, Sn
1995.
Management of Suspected Neuroleptic Malignant Syndrome.
The Canadian Journal of Psychiatry,
Vol. 40,
Issue. 9,
p.
545.
Dent, J.
1995.
Catatonic syndrome following recovery from neuroleptic malignant syndrome.
Journal of Intellectual Disability Research,
Vol. 39,
Issue. 5,
p.
457.
Hawkins, John M.
Archer, Katharine J.
Strakowski, Stephen M.
and
Keck, Paul E.
1995.
Somatic Treatment of Catatonia.
The International Journal of Psychiatry in Medicine,
Vol. 25,
Issue. 4,
p.
345.
Buckley, P F
and
Hutchinson, M
1995.
Neuroleptic malignant syndrome..
Journal of Neurology, Neurosurgery & Psychiatry,
Vol. 58,
Issue. 3,
p.
271.
Kohen, D.
and
Bristow, M.
1996.
Neuroleptic malignant syndrome.
Advances in Psychiatric Treatment,
Vol. 2,
Issue. 4,
p.
151.
Fink, Max
1996.
Neuroleptic malignant syndrome and catatonia: One entity or two?.
Biological Psychiatry,
Vol. 39,
Issue. 1,
p.
1.
Simpson, George M
and
Pi, Edmond H
1996.
What's Happening to the Neuroleptic Malignant Syndrome?.
Psychiatric Annals,
Vol. 26,
Issue. 4,
p.
172.
Bush, G.
Fink, M.
Petrides, G.
Dowling, F.
and
Francis, A.
1996.
Catatonia. II. Treatment with lorazepam and electroconvulsive therapy.
Acta Psychiatrica Scandinavica,
Vol. 93,
Issue. 2,
p.
137.
Fink, Max
1996.
Response to "Neuroleptic Malignant-Like Syndrome due to Cyclobenzaprine?".
Journal of Clinical Psychopharmacology,
Vol. 16,
Issue. 1,
p.
97.
Fink, Max
1996.
Neuroleptic malignant syndrome and catatonia: One entity or two?.
Biological Psychiatry,
Vol. 40,
Issue. 5,
p.
431.
TU, JUN-BI
Tu, Jun-bi
and
Myers, Kathleen
1996.
Neuroleptic Malignant Syndrome: A Psychopharmacogenetic Perspective.
Journal of Child and Adolescent Psychopharmacology,
Vol. 6,
Issue. 2,
p.
151.
Myers, Kathleen
1996.
Author's reply.
Journal of Child and Adolescent Psychopharmacology,
Vol. 6,
Issue. 2,
p.
152.
Fricchione, Gregory
Bush, George
Fozdar, Manish
Francis, Andrew
and
Fink, Max
1997.
Recognition and Treatment of the Catatonic Syndrome.
Journal of Intensive Care Medicine,
Vol. 12,
Issue. 3,
p.
135.
Petrides, Georgios
Fink, Max
Bush, George
and
Francis, Andrew
1997.
Reply.
Acta Psychiatrica Scandinavica,
Vol. 95,
Issue. 4,
p.
358.
Blumer, Dietrich
1997.
Catatonia and the neuroleptics: Psychobiologic significance of remote and recent findings.
Comprehensive Psychiatry,
Vol. 38,
Issue. 4,
p.
193.
Berardi, Domenico
Amore, Mario
Keck, Paul E
Troia, Mario
and
Dell’Atti, Maddalena
1998.
Clinical and pharmacologic risk factors for neuroleptic malignant syndrome: a case–control study.
Biological Psychiatry,
Vol. 44,
Issue. 8,
p.
748.
eLetters
No eLetters have been published for this article.